EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model

Understanding the molecular basis of drug resistance and utilising this information to overcome chemoresistance remains a key challenge in oncology. Here we report that survivin, a key protein implicated in drug resistance, is overexpressed in cancer stem cell pool of doxorubicin-resistant breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Gantier, Michael P., Xiang, Dongxi, Bean, Andrew G, Bruce, Matthew, Zhou, Shu-Feng, Khasraw, Mustafa, Ward, Alister, Wang, Li, Wei, Ming Q., AlShamaileh, Hadi, Chen, Lijue, She, Xiaodong, Lin, Jia, Kong, Lingxue, Shigdar, Sarah, Duan, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672025/
https://www.ncbi.nlm.nih.gov/pubmed/26681989
http://dx.doi.org/10.7150/thno.11692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672025/
https://www.ncbi.nlm.nih.gov/pubmed/26681989
http://dx.doi.org/10.7150/thno.11692

Ejemplares similares